Breast Cancer

If you have been NEWLY DIAGNOSED  START HERE 

Cancer Journey


VIDEOS

November is Lung Cancer Awareness Month. To mark it this year, GRACE is celebrating the empowered lung cancer patient. In this video, Dr. Jared Weiss...

ARTICLES

From the Grace Archives | Originally Published July 30, 2011 | By Dr West Our weekly thoracic tumor board, a multidisciplinary meeting with multiple...
From the GRACE Archives -- Originally Published November 5, 2009 | By Dr. Weiss I treat cancer for two and only two reasons. I want my patients to...

From the GRACE Archives - Originally Published August 26, 2009 | By Dr Pennell OK, I hope you all aren’t bored to tears by this topic by now, given...

From the GRACE Archives - Originally Published April 11, 2009 | By Dr Pennell This week in the Journal of Clinical Oncology, a group of clinical...
From the GRACE Archives - Originally Published November 21, 2009 | By Dr. Weiss I’ve been impressed by many things about GRACE and its members. Among...

COMMUNITY FORUM

RECENT POSTS

Last Comment by JanineT GRACE … on Mar 25, 2024 9:17 am

How to Vet a Treatment Idea

Article

From the GRACE Archives - Originally Published November 21, 2009 | By Dr. Weiss

I’ve been impressed by many things about GRACE and its members. Among these many things are the thirst for new information and better treatments. I also admire the openness of the members both to new ideas, and to questioning these ideas.

What Makes a Triple Negative Breast Cancer Negative - Reis Filho

Video
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS).

In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy.  

Current Standard of Care in Triple Negative Breast Cancer - Yardley

Video
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS).

In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy.  

Combination therapy IO + Chemo in Triple Negative Breast Cancer - Schmid

Video
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS).

In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy.  

Review of Recent Progress in Immunotherapy in Triple Negative Breast Cancer - Schmid

Video
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS).

In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy.  

BRCA Mutations What does it Mean When Choosing My Treatment - Litton

Video
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS).

In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy.  

Subscribe to Breast Cancer